HeartSine Samaritan PAD Defibrillators Recalled for Test Configuration Flaw
HeartSine samaritan PAD defibrillators shipped in test configuration may have incorrect CPR timing and delayed or no therapy delivery in cardiac events. Users should stop using affected units and contact the manufacturer.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a life-critical medical device with potential for serious harm, including failure to deliver or delayed delivery of defibrillation therapy during cardiac emergencies. However, no reported illnesses or injuries are documented in the source, making this a theoretical risk-of-harm scenario. Per the rubric, risk-of-harm products without reported injury warrant a score of 3 (High).
Plain-English summary
HeartSine samaritan PAD (Public Access Defibrillator) models, including SAM 350P, SAM 360P, SAM 450P, and SAM 500P, have been recalled by the FDA due to a test configuration issue. The affected defibrillators were shipped in an improper test configuration rather than a production-ready state.
Devices affected by this configuration may display incorrect language, provide incorrect CPR duration instructions (prompting only 5-second intervals), and analyze heart rhythm at inappropriate intervals. This could result in delayed delivery or complete failure to deliver defibrillation therapy during cardiac emergencies, creating a serious risk to patient safety.
The recall affects 12 units with distribution across the United States (Texas, California, Illinois, Colorado, Florida, North Carolina, and Michigan) and internationally (Netherlands, Japan, and New Zealand).
Users and healthcare facilities should immediately discontinue use of any affected defibrillators and contact HeartSine Technologies Ltd for instructions on returning the devices or obtaining service replacements.
The recalled product
- Product
- HeartSine samaritan PAD (Public Access Defibrillator): Type/Catalog: SAM 350P/350-UNIT-US-10, 350-STR-US-10, 350-STR-UK-10; SAM 360P/360-STR-JA-10, 360-STR-DE-10, 360-STR-UK-10; SAM 450P/450-UNIT-US-08, ; SAM 500P/500-BAS-UK-10
- Manufacturer
- HeartSine Technologies Ltd
- Category
- Medical Device — Defibrillator
- Affected units
- 12
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (18)
- Type/UDI-DI or GTIN/Serial Number: SAM 350P/05060167120671
- 05060167127670
- +M727SAM350P0/$$+7/17D00023014
- 18D00020508
- 19D00017655
- 20D00006524
- 21D91081653
- 22D91152391
- SAM 360P/05060167127687
- 05060167127311
- 5060167122927/21E91049810
- 23E90001379
- 23E90010409
- SAM 450P/05060167129773
- +M727SAM450P0/$$+7
- +M727SAM450P0/$$+7/17G00001893
- 18G00001553
- SAM 500P/05060167122453/22B91071233
Distribution
Related recalls
Same manufacturer · HeartSine Technologies Ltd
See all →- LowHeartSine Defibrillators Recalled for Missing Maintenance Supplement
FDA (Devices) · 2026-10-07
- HighHeartSine SAM Public Access Defibrillators Recalled for Damaged Membrane Tail
FDA (Devices) · 2026-09-16
- HighDefibrillator pad packs recalled over damaged pins disrupting electrical contact
FDA (Devices) · 2025-10-29
- HighHeartSine samaritan public access defibrillators may not deliver shocks properly
FDA (Devices) · 2025-08-06
- HighHeartSine Public Access Defibrillators Recalled for Voice Prompt Manufacturing Defect
FDA (Devices) · 2024-05-22
Same hazard · device malfunction
See all →- SevereMedtronic MiniMed Flex Insulin Pumps Recalled for Failed Verification Tests
FDA (Devices) · 2026-10-14
- ModerateWilson-Cook Recalls Hemospray Endoscopic Hemostat Due to Adherence Issues
FDA (Devices) · 2026-09-23
- HighDatex-Ohmeda Aisys Anesthesia Systems Recalled for Gas Mixer Defect
FDA (Devices) · 2026-09-23
- HighDatex-Ohmeda Aisys CS2 Anesthesia Systems Recalled for Gas Mixer Defect
FDA (Devices) · 2026-09-23
- HighDatex-Ohmeda Et Control Software Recalled for Anesthetic Delivery Interruption
FDA (Devices) · 2026-09-23
Similar recalls
- HighHeartSine Public Access Defibrillators Recalled for Voice Prompt Manufacturing Defect
FDA (Devices) · 2024-05-22
- HighHeartSine samaritan public access defibrillators may not deliver shocks properly
FDA (Devices) · 2025-08-06
- HighHeartsine Samaritan PAD defibrillators distributed with incorrect language configuration
FDA (Devices) · 2023-03-15
- HighHeartSine SAM Public Access Defibrillators Recalled for Damaged Membrane Tail
FDA (Devices) · 2026-09-16
- LowHeartSine Defibrillators Recalled for Missing Maintenance Supplement
FDA (Devices) · 2026-10-07
- SevereHeartSine Samaritan 300/300P PAD Devices Recalled for Malfunction
FDA (Devices) · 2012-11-07